Zurück zu Projekte

18838.1 PFLS-LS

Development of early lead-like small molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii.

Zusammenfassung

Development of early lead-like small molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii.

Weitere Texte

Abstract

Acinetobacter baumannii is a Gram-negative bacterium of the ESKAPE-pathogen group and listed as one of the top priority dangerous organisms. The majority of clinical A. baumannii isolates (63%) are multidrug resistant. This project aims at developing an early lead-like small molecule against a transcriptional regulator of Acinetobacter ssp. These molecules will represent a new class of antibiotics active against a novel target family in Gram-negative antibacterial research.

Beteiligte

Marc Gitzinger

Wirtschaftspartner

BioVersys AG Marc Gitzinger Hochbergerstrasse 60c 4057 Basel BS CH

Richard Kammerer

Kontaktperson

richard.kammerer@psi.ch

PSI, Paul Scherrer Institut Richard Kammerer OFLC/ 106 5232 Villigen PSI AG CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2017-02-28
Enddatum
2019-12-31
Bewilligte Gesamtkosten
CHF 361238.00
Sektion
60 Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%